Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)Axel Grothey, Mark Kozloff, Daniel J. Sargent et al.|Journal of Clinical Oncology|2008Cited by 695
Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE)Eric Hedrick, Axel Grothey, Mark Kozloff et al.|Journal of Clinical Oncology|2006Cited by 87